Skip to content

Platelet proteomics and metabolomics studies of general cancer and hematological-related diseases

Platelet proteomics and metabolomics studies of general cancer and hematological-related diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124055
Enrollment
Unknown
Registered
2026-05-06
Start date
2026-05-10
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal tumors, inflammatory bowel disease, ulcerative colitis, Crohn's disease, colon polyps

Interventions

Healthy control group:None
Inflammatory enteritis group:None

Sponsors

The Second Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Based on the comprehensive diagnosis including clinical manifestations, laboratory tests, imaging findings, histological findings, and endoscopic observations, the diagnosis is consistent with colorectal cancer, inflammatory bowel disease, and colonic polyps.

Exclusion criteria

Exclusion criteria: 1.Pregnant women or lactating women; 2.Other cancers except colorectal cancer; 3.The condition is critical, making it difficult to make a definite assessment of the effectiveness and safety of the treatment. 4.Those who have undergone radical surgery for colorectal cancer;

Design outcomes

Primary

MeasureTime frame
metabolomics;proteomics;

Secondary

MeasureTime frame
Clinical and demographic indicators;

Countries

China

Contacts

Public ContactZuojian Hu

The Second Affiliated Hospital of Guangxi Medical University

15778030661@163.com+86 771 327 7245

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 16, 2026